Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
0.9801 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 35.627 | 66.886 | 130.101 | 122.162 | 43.777 | 6.552 |
| Short Term Investments
| 135.93 | 176.636 | 47.504 | 72.075 | 0 | 0 |
| Cash and Short Term Investments
| 171.557 | 243.522 | 177.605 | 194.237 | 43.777 | 6.552 |
| Net Receivables
| 0.398 | 0.225 | 0 | 0 | 0.109 | 0.03 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.351 | 2.868 | 2.724 | 4.424 | 0.543 | 1.136 |
| Total Current Assets
| 178.306 | 246.615 | 180.329 | 198.661 | 44.429 | 7.178 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0.339 | 0.503 | 0.27 | 0.036 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 59.968 | 62.553 | 15.837 | 31.619 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.379 | 0.454 | 0.151 | 0.014 | 0 | 0.144 |
| Total Non-Current Assets
| 60.686 | 63.51 | 16.258 | 31.669 | 0 | 0.144 |
| Total Assets
| 238.992 | 310.125 | 196.587 | 230.33 | 44.429 | 7.322 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 5.648 | 1.379 | 1.64 | 1.088 | 0.531 | 0.223 |
| Short Term Debt
| 0.266 | 1.732 | 0.21 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 21.826 | 9.86 | 5.962 | 4.059 | 5.836 | 1.119 |
| Total Current Liabilities
| 27.607 | 12.971 | 7.812 | 5.147 | 6.367 | 1.342 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 29.569 | 27.621 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.97 | 2.56 | 0 | 0 | 56.653 | 17.4 |
| Total Non-Current Liabilities
| 29.569 | 30.181 | 0 | 0 | 56.653 | 17.4 |
| Total Liabilities
| 57.176 | 43.152 | 7.812 | 5.147 | 63.02 | 18.742 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.006 | 0.006 | 0.004 | 0.004 | 0 | 0 |
| Retained Earnings
| -325.127 | -222.798 | -170.427 | -127.571 | -26.965 | -19.64 |
| Accumulated Other Comprehensive Income/Loss
| -0.048 | 0.312 | -0.751 | -0.231 | 0 | 0 |
| Other Total Stockholders Equity
| 506.985 | 489.453 | 359.949 | 352.981 | 65.027 | 25.62 |
| Total Shareholders Equity
| 181.816 | 266.973 | 188.775 | 225.183 | -18.591 | -11.42 |
| Total Equity
| 181.816 | 266.973 | 188.775 | 225.183 | -18.591 | -11.42 |
| Total Liabilities & Shareholders Equity
| 238.992 | 310.125 | 196.587 | 230.33 | 44.429 | 7.322 |